Singular Genomics Systems has filed a patent for silicon-containing detectable compounds and their methods of use. The abstract and claim provide limited information, but it suggests that the patent involves a specific compound or salt thereof with a defined formula. GlobalData’s report on Singular Genomics Systems gives a 360-degree view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData

Report-cover

Premium Insights Singular Genomics Systems Inc - Company Profile

Buy the Report

Premium Insights

The gold standard of business intelligence.

Find out more

According to GlobalData’s company profile on Singular Genomics Systems, DNA polymerase compositions was a key innovation area identified from patents. Singular Genomics Systems's grant share as of September 2023 was 24%. Grant share is based on the ratio of number of grants to total number of patents.

Silicon-containing detectable compounds and their methods of use

Source: United States Patent and Trademark Office (USPTO). Credit: Singular Genomics Systems Inc

A recently filed patent (Publication Number: US20230295437A1) describes a compound or salt thereof with a specific chemical formula. The compound can have various substituents and functional groups, including alkyl, heteroalkyl, cycloalkyl, heterocycloalkyl, aryl, and heteroarylene. The compound can also be a polymer. The patent claims cover different variations of the compound, including specific substitutions and combinations of substituents.

The patent also describes a method for detecting the presence of an agent using the compound. The method involves covalently binding the compound to the agent and exposing it to absorption light. The emission wavelength is then detected to determine the presence of the agent. The agent can be an oligonucleotide, protein, or compound.

Overall, the patent claims cover a compound or salt thereof with a specific chemical formula and various substituents. The compound can be used in a method for detecting the presence of an agent. The patent provides detailed descriptions of the compound and its variations, as well as the method for detection.

To know more about GlobalData’s detailed insights on Singular Genomics Systems, buy the report here.

Premium Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies